doi: 10.1021/acs.biochem.8b00006 31 BogdanARMiyazawaMHashimotoKTsujiY
Thats where wastewater surveillance comes in
Di Matteo A, Bathon JM, Emery P
The results of studies confirming a high efficacy of PCSK9 inhibitors administered immediately after an ACS (the EVOPACS and EVACS studies with evolocumab [179, 180] and the VCU-alirocRT study with alirocumab [181]) are also worth noting, as they were the starting point for recommendation concerning initiation of treatment with PCSK9 inhibitors during hospitalisation (recommendation level IIa C) in the most recent ESC/EAS 2019 guidelines [9]
However, the result faded after 3 months, which made the researchers debate whether the impact could be from the initial frequent provider visits, motivated lifestyle choices, or the excessive nausea and malaise experienced on initiation of GLP-1 receptor agonists, which could have reduced the alcohol intake during the first few months
Labs are checked at baseline and 8-12 weeks to ensure IGF-1, fasting glucose, and lipids are in healthy ranges